l132 (ATCC)
Structured Review

L132, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 181 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/l132/product/ATCC
Average 94 stars, based on 181 article reviews
Images
1) Product Images from "Modulation of AMPK/NLRP3 Signaling Mitigates Radiation-Induced Lung Inflammation by a Synthetic Lipoxin A4 Analogue"
Article Title: Modulation of AMPK/NLRP3 Signaling Mitigates Radiation-Induced Lung Inflammation by a Synthetic Lipoxin A4 Analogue
Journal: International Journal of Molecular Sciences
doi: 10.3390/ijms262210832
Figure Legend Snippet: Structural characterization and in vitro evaluation of the radioprotective properties of CYNC-2. ( A ) Chemical structure of the synthetic lipoxin A 4 analogue CYNC-2. Structural modifications include incorporation of a dioxolane ring system and substitutions at both upper and lower branches to enhance oxidative stability. ( B ) Clonogenic assay evaluating the effects of CYNC-2 (10 nM) on radiation-induced cytotoxicity in normal (L132) and cancerous (A549) lung epithelial cells at doses of 0, 2, 4, 6, and 10 Gy. ( C ) WST-1 cell viability assay performed across a concentration range of CYNC-2 (0.0001–100 nM) in L132 and A549 cells to assess potential cytotoxicity or proliferative effects. ( D ) NF-κB luciferase reporter assay in LPS-stimulated THP-1 Lucia™ monocytes (InvivoGen). Cells were pretreated with CYNC-2, dexamethasone, native LXA 4 , or vehicle control for 2 h prior to stimulation with lipopolysaccharide (LPS, 50 ng/mL). After 24 h, luciferase activity was measured in the culture supernatant using a Lucia detection reagent to quantify NF-κB activation. Dexamethasone was included as a reference compound due to its well-established role as a potent NF-κB inhibitor in in vitro inflammatory assays. Data are presented as mean ± standard deviation. **** p < 0.0001.
Techniques Used: In Vitro, Clonogenic Assay, Viability Assay, Concentration Assay, Luciferase, Reporter Assay, Control, Activity Assay, Activation Assay, Standard Deviation
Figure Legend Snippet: In vitro and in vivo evaluation of the anti-inflammatory effects of CYNC-2. ( A ) Relative mRNA expression of inflammation-related cytokines (IL-1β, IL-6, and TGF-β1) in L132 cells following 6-Gy irradiation with or without CYNC-2 treatment, assessed by quantitative real-time PCR (qRT-PCR). ( B ) Serum levels of the same cytokines measured by ELISA in irradiated mice treated with CYNC-2. Predn: Prednisolone (positive control). Data are presented as the mean ± standard deviation. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Techniques Used: In Vitro, In Vivo, Expressing, Irradiation, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Positive Control, Standard Deviation
Figure Legend Snippet: CYNC-2 restores AMPK activation and modulates PI3K/mTOR pathway in irradiated lung tissues and epithelial cells. ( A ) Immunofluorescence staining of L132 cells showing phosphorylated AMPK (pAMPK), total AMPK (green), and nuclei (DAPI, blue) 24 h after 6-Gy irradiation, with or without CYNC-2 pretreatment (1 nM, 2 h prior to IR). CYNC-2 restored pAMPK expression suppressed by irradiation. Images captured at 40× magnification; scale bar = 50 μm. ( B ) Immunohistochemical staining of irradiated mouse lung tissues showing expression of PI3K, pAMPK, total AMPK, p-mTOR, and total mTOR. CYNC-2 treatment increased pAMPK and reduced PI3K and p-mTOR expression. Representative images at 4× and 40× magnification; scale bar = 50 μm. Predn: Prednisolone (positive control). ( C ) Western blotting analysis of P-Akt and p-PI3K expression after in L132 cells exposed to 6 Gy IR. Data are presented as mean ± standard deviation. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Techniques Used: Activation Assay, Irradiation, Immunofluorescence, Staining, Expressing, Immunohistochemical staining, Positive Control, Western Blot, Standard Deviation
Figure Legend Snippet: CYNC-2 suppresses radiation-induced NLRP3 inflammasome activation in vitro and in vivo. ( A ) Immunofluorescence analysis of L132 cells showing expression of phosphorylated NF-κB (pNF-κB), total NF-κB, and NLRP3 (green) with nuclear counterstaining (DAPI, blue). Cells were pretreated with CYNC-2 (1 nM) or vehicle for 2 h, followed by 6-Gy X-ray irradiation. Images were captured 24 h post-irradiation at 40× magnification. Scale bar = 50 μm. ( B ) Representative immunohistochemical staining of irradiated mouse lung tissues showing expression of NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC), cleaved caspase-1, and NEK7. CYNC-2 or prednisolone treatment markedly reduced the expression of inflammasome markers compared with the irradiated control group. Images captured at 4× and 40× magnification. Scale bar = 50 μm. Predn: Prednisolone (positive control). Data are presented as mean ± standard deviation. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Techniques Used: Activation Assay, In Vitro, In Vivo, Immunofluorescence, Expressing, Irradiation, Immunohistochemical staining, Staining, Control, Positive Control, Standard Deviation
